Meta-analysis shows prevalence of statin intolerance Is low
Feb 16, 2022
The prevalence of statin intolerance was 9.1% overall; significant associations were seen for age, female gender, Asian and Black race, obesity and diabetes mellitus.
Monitoring blood pressure at home more acceptable to adults
Sep 27, 2021
For adults with elevated blood pressure, monitoring it at home is more acceptable than at a clinic or kiosk or using a 24-hour ambulatory blood pressure monitor, according to a study presented at the American...
High AI-ECG-AF risk score tied to worse cognition, cognitive decline
May 11, 2022
A high probability of atrial fibrillation by AI-ECG-AF score correlated with cerebral infarcts on MRI.
Daily multivitamin does not cut cancer incidence in older adults
Mar 18, 2022
A same randomized two-by-two factorial trial shows that cocoa extract did not significantly reduce total cardiovascular events in older adults.
Data elements, definitions for COVID-19 complications detailed
Jun 27, 2022
The clinical lexicon presents data elements related to cardiovascular and noncardiovascular complications of COVID-19.
Subjective cognitive impairment linked to MACE in T2DM
Apr 26, 2022
Among individuals with type 2 diabetes, a country-standardized cognitive score may predict risk for cardiovascular events.
Newly detected vascular risk factors common in stroke patients
Jun 30, 2022
Newly diagnosed vascular risk factors common in patients with acute ischemic stroke include dyslipidemia, hypertension and atrial fibrillation.
Muscle strengthening may cut risk for noncommunicable disease
Mar 01, 2022
Muscle-strengthening activities were inversely linked to risks for all-cause mortality and major noncommunicable diseases.
2019 to 2020 saw 16.8 percent increase in U.S. death rate
Dec 22, 2021
The two leading causes of death continued to be heart disease and cancer, with COVID-19 the third leading cause of death in 2020.
COVID-19 vaccine does not increase CV event risk in those with existing disease
Jun 24, 2022
The findings show the safety of the BNT162b2 or CoronaVac vaccines in patients with cardiovascular disease.